Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
Surgery|March 1, 1982
Transplantation in patients with a history of renal cell carcinoma: long-term results and clinical considerationsE K Spees, J A Light, E J Smith, et al.
Der Urologe. Ausg. A|January 10, 1998
[Clinical stage I mature teratoma of the testis--retroperitoneal lymphadenectomy or surveillance?]A Heidenreich, S Neubauer, F K Mostofi, et al.
The Journal of Urology|October 1, 1996
Elevated levels of apoptosis regulator proteins p53 and bcl-2 are independent prognostic biomarkers in surgically treated clinically localized prostate cancerJ J Bauer, I A Sesterhenn, F K Mostofi, et al.
The Prostate|January 1, 1989
Crystalloids in latent prostatic carcinomaM Furusato, H Kato, H Takahashi, et al.
The Journal of Urology|September 1, 1996
Ki-67 expression is a prognostic marker of prostate cancer recurrence after radical prostatectomyM C Bettencourt, J J Bauer, I A Sesterhenn, et al.
The Prostate. Supplement|January 11, 1992
Preliminary results of three-dimensional reconstruction of previously imaged prostatesI A Sesterhenn, F K Mostofi, R R Mattrey, et al.
The Prostate|June 15, 1997
Prostate-specific antigen-detected prostate cancer (stage T1c): an analysis of whole-mount prostatectomy specimensT H Douglas, D G McLeod, F K Mostofi, et al.
The Journal of Urology|August 1, 1997
Immunohistochemical expression of Ki-67 to predict lymph node involvement in clinical stage I nonseminomatous germ cell tumorsA Heidenreich, N S Schenkmann, I A Sesterhenn, et al.
JAMA|October 25, 1995
Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American menJ W Moul, I A Sesterhenn, R R Connelly, et al.
Cancer|September 1, 1994
Relative sensitivity and specificity of serum prostate specific antigen (PSA) level compared with age-referenced PSA, PSA density, and PSA change. Data from the American Cancer Society National Prostate Cancer Detection ProjectC Mettlin, P J Littrup, R A Kane, et al.
Pageof 9